TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Chemical compound clears cellular waste, protects neurons in model of frontotemporal dementia
    April 13, 2026
  • Tiny tools, sharp aim: Nanobodies target tumors with precision
    April 12, 2026
  • Most detailed map to date of breast tissue changes reveals role of menopause in cancer susceptibility
    April 7, 2026
  • To Understand How the Human Brain Ages, Science Reveals New Insights From Mice
    April 7, 2026
  • Study reveals differences in early Alzheimer’s brain markers across diverse populations 
    April 3, 2026
More news.
© 2017 - 2026 Innovita Research | Privacy policy